GlaxoSmithKline plc (GSK) is a British pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham; as of 2017 GSK was by revenue, one of the world’s top 10 largest pharmaceutical companies. After successfully completing our first project at the GSK Ware site in 2015, MIDDAS were awarded the Ellipta Phase 4 project to provide partitioning, ceilings and doors to create cleanroom envelopes for manufacture of the advanced Ellipta range of inhalers.
MIDDAS were tasked with further developing our M100 bi-panel, partition system to provide seamless integration between walls, ceilings and floors, incorporating various GSK-specific details. A walk-on ceiling was specified with the requirement to remove any element within the ceiling, without affecting adjacent panels, to allow rapid installation and reconfiguration of machinery throughout the lifespan of the facility.
Working closely with the GSK design and engineering team, MIDDAS developed integrated, flush fitting coving for vertical and horizontal connections, utilising 3D printing technology for corner connections and a variable skirting profile to accommodate different floor finishes. These details added to the existing features of the M100 bi-panel system to enhance it further and set it apart from competitor systems. MIDDAS product development team designed and engineered a new walk-on ceiling system to provide the individual, removable element of the design brief and accommodate the multiple variations in height and specific detail requirements of the specification.